It seems that it is straightforward from a comedy book, but the widow is a real, working titanium heart. The metal device is eventually developed as an alternative to the human donor organs, but last year it was used as a stop gap for hospital patients waiting for a transplant. According to its creators And representatives from St. Vincent’s Hospital in Sydney, Australia, recently identified a significant milestone: a man survived for more than 100 days with his Biocor Employment, and even temporarily relieved with medical facilities and was pumped inside it.
The basic principles of the titanium device were first considered by a biomedical engineer named Daniel Tims in 2001. Tammus, the son of a plumber, started By imitating the human circulation system using hardware store pipes and valves, but in the next 25 years, it was developed what would be Biocor. The closing messenger works without real valves and relies on the same moving part. This magnetically lifted the router revolves between two chambers while never comes into contact with the titanium frame, and thus gradually eliminates the risk of corrosion or malfunction. The entire device weighs less than £ 1.5, and runs from the outer battery located on the stomach. It is so small to fit both men and women as well as 12 years of age. Research also shows that bio -car can help an adult during strict exercise.
In 2024, doctors in the US and Australia made history To install successfully A total of five patients’ fist -shaped pump. One of them, a person of the 40s, could manage to walk only a few feet before losing the breath, to deal with the severe heart failure. However, in the aftermath of a six -hour procedure, the patient regained so much strength and movement until the donor’s heart was available. He returned to receive his human transplant in early March, and is now recovering, according to a Announcement of March 12 From St. Vincent’s hospital.
“Heart failure kills about 5,000 5,000 Australians every year. We have worked towards this moment for years and we have been the first team in Australia to carry out this procedure, “Paul Johns, the heart surgeon involved in this procedure,” Said in a separate statement.
Biocor is not yet commercially available, but by the end of 2025, four more devices are being developed in Australia. In the future, these titanium hearts cannot only act as temporary tools, but instead offer long -term and perhaps permanent alternatives.